Circulating Metabolite Predictors of Glycemia in Middle-aged Men and Women

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2012 May 8

PMID 22563043

Citations 109

Authors

Peter Wurtz

Mika Tiainen

Ville-Petteri Makinen

Antti J Kangas

Pasi Soininen

Juha Saltevo

Sirkka Keinanen-Kiukaanniemi

Pekka Mantyselka

Terho Lehtimaki

Markku Laakso

Antti Jula

Mika Kahonen

Mauno Vanhala

Mika Ala-Korpela

Affiliations

Soon will be listed here.

Abstract

Objective: Metabolite predictors of deteriorating glucose tolerance may elucidate the pathogenesis of type 2 diabetes. We investigated associations of circulating metabolites from high-throughput profiling with fasting and postload glycemia cross-sectionally and prospectively on the population level.

Research Design And Methods: Oral glucose tolerance was assessed in two Finnish, population-based studies consisting of 1,873 individuals (mean age 52 years, 58% women) and reexamined after 6.5 years for 618 individuals in one of the cohorts. Metabolites were quantified by nuclear magnetic resonance spectroscopy from fasting serum samples. Associations were studied by linear regression models adjusted for established risk factors.

Results: Nineteen circulating metabolites, including amino acids, gluconeogenic substrates, and fatty acid measures, were cross-sectionally associated with fasting and/or postload glucose (P < 0.001). Among these metabolic intermediates, branched-chain amino acids, phenylalanine, and α1-acid glycoprotein were predictors of both fasting and 2-h glucose at 6.5-year follow-up (P < 0.05), whereas alanine, lactate, pyruvate, and tyrosine were uniquely associated with 6.5-year postload glucose (P = 0.003-0.04). None of the fatty acid measures were prospectively associated with glycemia. Changes in fatty acid concentrations were associated with changes in fasting and postload glycemia during follow-up; however, changes in branched-chain amino acids did not follow glucose dynamics, and gluconeogenic substrates only paralleled changes in fasting glucose.

Conclusions: Alterations in branched-chain and aromatic amino acid metabolism precede hyperglycemia in the general population. Further, alanine, lactate, and pyruvate were predictive of postchallenge glucose exclusively. These gluconeogenic precursors are potential markers of long-term impaired insulin sensitivity that may relate to attenuated glucose tolerance later in life.

Citing Articles

Serum Lipidomic Analysis of T2DM Patients: A Potential Biomarker Study.

Qi W, Yang C, Li J, Bao L Diabetes Metab Syndr Obes. 2025; 18:529-539.

PMID: 39990177 PMC: 11847430. DOI: 10.2147/DMSO.S505863.

Effects of Dietary Medium-Chain Triglyceride Supplementation on the Serum Metabolome of Young Adult and Senior Canines.

Pan Y, Sindelar M, Stancliffe E, Shriver L, Middleton R, Patti G Animals (Basel). 2025; 14(24.

PMID: 39765481 PMC: 11672509. DOI: 10.3390/ani14243577.

Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes.

Chen Z, Lu C, Dreyfuss J, Tiwari G, Shi X, Zheng S Diabetes Care. 2024; 47(9):1597-1607.

PMID: 38935559 PMC: 11362122. DOI: 10.2337/dc23-2441.

Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications.

Zhang F, Shan S, Fu C, Guo S, Liu C, Wang S Molecules. 2024; 29(11).

PMID: 38893405 PMC: 11173766. DOI: 10.3390/molecules29112530.

Type 2 diabetes metabolomics score and risk of progression to type 2 diabetes among women with a history of gestational diabetes mellitus.

Tobias D, Hamaya R, Clish C, Liang L, Deik A, Dennis C Diabetes Metab Res Rev. 2024; 40(1):e3763.

PMID: 38287718 PMC: 10842268. DOI: 10.1002/dmrr.3763.

References

Ahonen T, Kautiainen H, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M . Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med. 2008; 35(6):598-601. DOI: 10.1016/j.amepre.2008.09.011. View

Huffman K, Shah S, Stevens R, Bain J, Muehlbauer M, Slentz C . Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009; 32(9):1678-83. PMC: 2732163. DOI: 10.2337/dc08-2075. View

Saukkonen T, Cederberg H, Jokelainen J, Laakso M, Harkonen P, Keinanen-Kiukaanniemi S . Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011; 34(10):2314-6. PMC: 3177731. DOI: 10.2337/dc11-0183. View

Sattar N, Scherbakova O, Ford I, OReilly D, Stanley A, Forrest E . Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes. 2004; 53(11):2855-60. DOI: 10.2337/diabetes.53.11.2855. View

Bain J, Stevens R, Wenner B, Ilkayeva O, Muoio D, Newgard C . Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes. 2009; 58(11):2429-43. PMC: 2768174. DOI: 10.2337/db09-0580. View

Faerch K, Borch-Johnsen K, Holst J, Vaag A . Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?. Diabetologia. 2009; 52(9):1714-23. DOI: 10.1007/s00125-009-1443-3. View

Newgard C, An J, Bain J, Muehlbauer M, Stevens R, Lien L . A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009; 9(4):311-26. PMC: 3640280. DOI: 10.1016/j.cmet.2009.02.002. View

Wang T, Larson M, Vasan R, Cheng S, Rhee E, McCabe E . Metabolite profiles and the risk of developing diabetes. Nat Med. 2011; 17(4):448-53. PMC: 3126616. DOI: 10.1038/nm.2307. View

Tabak A, Jokela M, Akbaraly T, Brunner E, Kivimaki M, Witte D . Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009; 373(9682):2215-21. PMC: 2726723. DOI: 10.1016/S0140-6736(09)60619-X. View

10.

Savage D, Petersen K, Shulman G . Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007; 87(2):507-20. PMC: 2995548. DOI: 10.1152/physrev.00024.2006. View

11.

Crawford S, Hoogeveen R, Brancati F, Astor B, Ballantyne C, Schmidt M . Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol. 2010; 39(6):1647-55. PMC: 2992628. DOI: 10.1093/ije/dyq126. View

12.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

13.

Vanhala M, Kumpula L, Soininen P, Kangas A, Ala-Korpela M, Kautiainen H . High serum adiponectin is associated with favorable lipoprotein subclass profile in 6.4-year follow-up. Eur J Endocrinol. 2011; 164(4):549-52. DOI: 10.1530/EJE-10-1065. View

14.

HERS H, Hue L . Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem. 1983; 52:617-53. DOI: 10.1146/annurev.bi.52.070183.003153. View

15.

Wurtz P, Makinen V, Soininen P, Kangas A, Tukiainen T, Kettunen J . Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes. 2012; 61(6):1372-80. PMC: 3357275. DOI: 10.2337/db11-1355. View

16.

Fournier T, Porquet D . Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000; 1482(1-2):157-71. DOI: 10.1016/s0167-4838(00)00153-9. View

17.

Lee Y, Choi J, Hwang I, Lee J, Lee J, Kim A . Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem. 2010; 285(29):22174-85. PMC: 2903347. DOI: 10.1074/jbc.M109.085464. View

18.

Laferrere B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B . Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med. 2011; 3(80):80re2. PMC: 3656497. DOI: 10.1126/scitranslmed.3002043. View

19.

Wurtz P, Soininen P, Kangas A, Makinen V, Groop P, Savolainen M . Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis. Mol Biosyst. 2010; 7(2):385-93. DOI: 10.1039/c0mb00066c. View

20.

Novoa F, Boronat M, Saavedra P, Diaz-Cremades J, Varillas V, La Roche F . Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care. 2005; 28(10):2388-93. DOI: 10.2337/diacare.28.10.2388. View